• Upcoming Dividends

    The companies about to go ex-dividend are below.  Please note the ex-date of 30 March if you’re planning to buy shares in either of these two real estate investment trusts. To qualify you’ll have to have bought your shares this week. Of course, you can expect more of these notices in the future as new…

  • Trades Executed

    We’ve executed these trades.

  • Trades Executed

    We’ve executed these trades.

  • 260320 SOTM: Goodman Group (Vincent Wales)

    In this month’s featured update, Scott Phillips and Vincent Wales dive into the evolving world of industrial real estate and digital infrastructure. They discuss why Goodman Group (ASX: GMG) has transitioned from a traditional property trust into a vital ‘picks and shovels’ play for the global AI revolution. By partnering with titans like Amazon (NASDAQ:…

  • Will Ozempic take some weight off the ResMed share price?

    Sleep apnoea is a widespread and serious condition, affecting many areas of our health — and ResMed’s (ASX:RMD) CPAP machines have been at the forefront of treatment. But will Ozempic’s (and other brands’) weight loss drugs put a dent in ResMed’s market? Our Chief Investment Officer, Scott Phillips, sits down with Motley Fool analyst Mitchell…

  • The “Why Not Both?” Strategy: Unlocking Dividend Growth – Team Talk March 2026

    Scott Phillips and Edward Vesely discuss a powerful investing approach that bridges the gap between immediate income and long-term capital appreciation. While many investors feel forced to choose between high-yield “value” companies or non-paying “growth” companies, Ed explains why the most spectacular returns often come from companies that grow their payouts consistently over decades. By…